Diabetes Research and Clinical Practice
Volume 66, Issue 1 , Pages 23-29, October 2004

Postprandial versus preprandial dosing of biphasic insulin aspart in elderly type 2 diabetes patients

  • Mark L. Warren

      Affiliations

    • Department of Endocrinology and Metabolism, Physicians East, PA, 1850 W. Arlington Blvd., Greenville, NC 27834, USA
    • Corresponding Author InformationCorresponding author.
  • ,
  • Martin J. Conway

      Affiliations

    • Lovelace Scientific Resources Inc., Albuquerque, NM, USA
  • ,
  • Leslie J. Klaff

      Affiliations

    • Rainier Clinical Research Center Inc., Renton, WA, USA
  • ,
  • Julio Rosenstock

      Affiliations

    • Dallas Diabetes and Endocrine Center, Dallas, TX, USA
  • ,
  • Elsie Allen

      Affiliations

    • Novo Nordisk Pharmaceuticals, Inc., Princeton, NJ, USA

Received in revised form 28 January 2004; accepted 6 February 2004. published online 19 August 2004.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 The results of this study have been presented in poster form at the 2002 European Association for the Study of Diabetes (EASD) meeting in Budapest, Hungary (Warren et al., Postprandial dosing of NovoLog® Mix 70/30 in elderly subjects with type 2 diabetes, Diabetologia 2002, V45 Suppl. 2, A254, abstract 790).

PII: S0168-8227(04)00054-3

doi:10.1016/j.diabres.2004.02.010

Diabetes Research and Clinical Practice
Volume 66, Issue 1 , Pages 23-29, October 2004